Manal Nasser Almasad
Biographic Data
| ID | 8420498 |
|---|---|
| NAME | Manal Nasser Almasad |
| GIVEN NAMES | Manal Nasser |
| FAMILY NAME | Almasad |
| SIGNATURE | ALMASAD M N |
| AFFILIATIONS | National Guard Health Affairs |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Integrating nursing, pharmacy, and health records in Advanced Cardiovascular Life Support (ACLS) Protocols
Background: Cardiovascular illnesses are a leading cause of mortality globally, with coronary heart disease (CHD) being a common cardiovascular disorder that poses a significant health burden on communities. CHD is characterized by inadequate blood supply to the heart due to plaque buildup in the coronary arteries, resulting in chest discomfort, heart attacks, and potentially fatal outcomes. Aim of Work: The aim of the research is to recognize th…
Combination therapies
Background: Tuberculosis (TB) is a significant global health issue requiring prolonged treatment regimens that often involve multiple medications. Mycobacterium tuberculosis, the causative agent, is capable of residing in various tissue compartments during infection, leading to variability in drug accessibility and susceptibility. The complexity of the infection necessitates the use of antibiotic combinations to ensure that all affected areas are…
Pharmaceutical supply chain management
Background: The globalization of pharmaceutical supply chains has exposed significant vulnerabilities, enabling counterfeit medications to infiltrate the market. These counterfeit drugs not only fail to aid in the recovery of patients but also pose serious health risks due to their inferior quality. The World Health Organization (WHO) reports that in developing nations, approximately 10% of medications consumed by patients are counterfeit. This a…
Rise of Biosimilars
Background: Biologics have transformed the management of immune-mediated inflammatory conditions, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). The introduction of biosimilars—biologic medications that are highly similar and interchangeable with approved originators—has the potential to enhance market competition and improve patient access to necessary therapies. Aim of Work: This review aims to highlight the importance …
The impact of biotechnology on pharmaceutical manufacturing
Background _ Bioengineering tools have revolutionized the production of pharmaceutical bioproducts by streamlining processes and reducing the time required for development. These tools are applicable across various biological platforms, including plants, animals, and microorganisms, offering substantial advantages in the pharmaceutical industry. Aim of Work – This review aims to highlight the benefits and advancements in bioengineering tools for …
No prominent works on this page.
The impact of biotechnology on pharmaceutical manufacturing
Background _ Bioengineering tools have revolutionized the production of pharmaceutical bioproducts by streamlining processes and reducing the time required for development. These tools are applicable across various biological platforms, including plants, animals, and microorganisms, offering substantial advantages in the pharmaceutical industry. Aim of Work – This review aims to highlight the benefits and advancements in bioengineering tools for …
Rise of Biosimilars
Background: Biologics have transformed the management of immune-mediated inflammatory conditions, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). The introduction of biosimilars—biologic medications that are highly similar and interchangeable with approved originators—has the potential to enhance market competition and improve patient access to necessary therapies. Aim of Work: This review aims to highlight the importance …
Pharmaceutical supply chain management
Background: The globalization of pharmaceutical supply chains has exposed significant vulnerabilities, enabling counterfeit medications to infiltrate the market. These counterfeit drugs not only fail to aid in the recovery of patients but also pose serious health risks due to their inferior quality. The World Health Organization (WHO) reports that in developing nations, approximately 10% of medications consumed by patients are counterfeit. This a…
Combination therapies
Background: Tuberculosis (TB) is a significant global health issue requiring prolonged treatment regimens that often involve multiple medications. Mycobacterium tuberculosis, the causative agent, is capable of residing in various tissue compartments during infection, leading to variability in drug accessibility and susceptibility. The complexity of the infection necessitates the use of antibiotic combinations to ensure that all affected areas are…
Integrating nursing, pharmacy, and health records in Advanced Cardiovascular Life Support (ACLS) Protocols
Background: Cardiovascular illnesses are a leading cause of mortality globally, with coronary heart disease (CHD) being a common cardiovascular disorder that poses a significant health burden on communities. CHD is characterized by inadequate blood supply to the heart due to plaque buildup in the coronary arteries, resulting in chest discomfort, heart attacks, and potentially fatal outcomes. Aim of Work: The aim of the research is to recognize th…
Biotechnology and Related Fields (3 works) · Business (3 works) · Medicine (3 works) · Intensive care medicine (2 works) · Internal Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Risk analysis (engineering (2 works) · Advanced Breast Cancer Therapies (1 work) · Alternative medicine (1 work) · Biology (1 work)